Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer
Seyed Mohammad Ali Hosseini Rad1, Lida Langroudi, Fatemeh Kouhkan
1Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, 1997775555, Tehran, Iran, a.hoseini.rad@gmail.com.
Abstract:
Gene therapy as a therapeutic approach has been the dream for many scientists around the globe. Many strategies have been proposed and applied for this purpose, yet the void for a functional safe method is still apparent. Since most of the diseases are caused by undesirable upregulation (oncogenes) or downregulation (tumor suppressor genes) of genes, major gene therapy's techniques affect gene expression. Most of the methods are used in post-transcriptional level such as RNA inhibitory (RNAi) and splice-switching oligonucleotides (SSOs). RNAi blocks messenger RNA (mRNA) translation by mRNA degradation or interruption between attachments of mRNA with ribosomes' subunits. However, one of the novel methods is the usage of transcription factor targeted decoys. DNA decoys are the new generation of functional gene downregulatory oligonucleotides which compete with specific binding sites of transcription factors. Considering the exponential growth of this technique in both in vitro and in vivo studies, in this paper, we aim to line out the description, design, and application of decoys in research and therapy.
Insights
Transcription factor decoys offer a novel gene therapy approach by regulating gene expression. This method shows promise for research and therapeutic applications by targeting transcription factor binding sites.
Area of Science:
- Molecular Biology
- Gene Therapy
- Biotechnology
Background:
- Gene therapy aims to treat diseases by modifying gene expression.
- Current methods like RNA interference (RNAi) and splice-switching oligonucleotides (SSOs) primarily act post-transcriptionally.
- A need exists for safe and effective gene regulation strategies.
Purpose of the Study:
- To describe the mechanism, design, and applications of transcription factor decoys.
- To highlight decoys as a next-generation gene regulatory tool.
- To discuss the potential of decoys in both research and clinical settings.
Main Methods:
- Utilizing DNA decoys as functional gene downregulatory oligonucleotides.
- Designing decoys to compete with transcription factor binding sites.
- Evaluating decoy efficacy in vitro and in vivo.
Main Results:
- DNA decoys represent a novel strategy for modulating gene expression.
- Decoys offer a targeted approach to downregulate specific genes.
- The technique has demonstrated significant growth in experimental applications.
Conclusions:
- Transcription factor decoys are a promising new class of gene therapy agents.
- Decoys provide a method for precise control of gene expression.
- Further research and development hold potential for therapeutic breakthroughs.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Master Transcription Regulators
Master Transcription Regulators
MicroRNAs
MicroRNAs
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

